Birch Triterpenes PDE report and OEL report profile
Project-specific health-based exposure limit and occupational toxicology assessment support. The agreed scope may include PDE/ADE derivation, OEL derivation and OEB/OHC banding, based on the exact substance form, available evidence and intended product or workplace context.
The mechanism by which birch triterpene extract improves epidermolysis bullosa wounds is not fully established. The formulation has been associated with support of wound healing and epithelialisation; do not assign a defined receptor or antiviral mechanism.
Indications / reported uses
Treatment of partial-thickness wounds associated with dystrophic and junctional epidermolysis bullosa in adults and paediatric patients aged 6 months and older under the US Filsuvez indication
Scope is agreed for the exact substance form, intended use, exposure route, workplace context and available toxicological evidence.
PDE/ADE: critical effects, point of departure and justified adjustment factors.
OEL: inhalation hazards, exposure duration and workplace conditions.
OEB/OHC: evidence-based banding where requested; a band is not a numerical OEL.
Report: scientific rationale, source data, assumptions, uncertainties and limitations.
Assessment scope
PDE/ADE and OEL/OEB assessment
ReguSight provides project-specific support for Birch Triterpenes PDE/ADE, OEL and OEB/OHC assessments. This combined profile covers the Birch Triterpenes Permitted Daily Exposure (PDE) report (the Birch Triterpenes PDE report); Acceptable Daily Exposure (ADE) is the corresponding health-based daily exposure terminology. It also covers the Birch Triterpenes Occupational Exposure Limit (OEL) report (the Birch Triterpenes OEL report). PDE/ADE derivation and workplace exposure assessment are distinct scientific outputs; a band is not a numerical OEL.
Assessment may cover
PDE/ADE derivation using relevant toxicological evidence, critical effects, a justified point of departure and adjustment factors.
The EMA HBEL guideline informs PDE/ADE assessments in relevant shared-facility contexts. ECHA and HSE sources address workplace exposure limits; NIOSH provides occupational exposure-banding guidance. The applicable framework depends on the assessment question and jurisdiction.